Alexandria Real Estate Equities (ARE) has seen a dynamic series of events. Stakeholders have increased their investments in the firm, including Vestcor Inc, Tredje AP fonden, Analyst IMS Investment Management Services Ltd., Assetmark Inc., Amundi, PGGM Investments, Zurcher Kantonalbank Zurich Cantonalbank, and Davis Selected Advisers. In an unexpected turn, significant shares were also sold by PNC Financial Services Group Inc., Metis Global Partners LLC, National Pension Service, and Oppenheimer Asset Management Inc. ARE has announced pricing of
$550,000,000 public offering of senior notes due 2025 and a
$500 million common stock repurchase program. Its Q1 2025 dividend has increased by 22 cents or 4%. A positive
Financial performance was reported with 4Q24 and 2024 FFO per share diluted as $2.39 and $9.47 respectively. Yet some quarters reported a loss, with a 2Q24 net income per share diluted at $0.25. ARE also elected Claire Aldridge, PhD, to their Board of Directors.The firm recently declared it would hold its 1Q25 financial results conference call in April. ARE has signed a long-term lease with Vaxcyte, Inc. at the Alexandria Center for Life Science. It's recently reported to enable the delivery of innovative medicines addressing significant unmet medical needs.
Alexandria Real Estate Equities ARE News Analytics from Mon, 01 Apr 2024 07:00:00 GMT to Sat, 15 Mar 2025 10:49:36 GMT -
Rating 7
- Innovation 6
- Information 8
- Rumor 1
